A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab

A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab

Background. Pulmonary blastoma is a rare lung tumor similar to fetal lung tissues. Surgical resection at early stage is more curative than other treatments, but there is no standard treatment in unresectable cases. We show a case treated with carboplatin and paclitaxel plus bevacizumab. Case. A 68-...

Full description

Bibliographic Details
Main Authors:	Sakata, Shinya, Saeki, Sho, Hirooka, Sayuri, Hirosako, Susumu, Ichiyasu, Hidenori, Kohrogi, Hirotsugu
Format:	Online
Language:	English
Published:	Hindawi Publishing Corporation 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444532/

Similar Items

Primary Diaphragmatic Dedifferentiated Liposarcoma in a Young Female Patient after Delivery
by: Sakata, Shinya, et al.
Published: (2016)

Elevated serum IgG4 levels in two cases of paragonimiasis
by: Saeki, Sho, et al.
Published: (2015)

Cisplatin-Induced Eosinophilic Pneumonia
by: Ideguchi, Hideharu, et al.
Published: (2014)

Biphasic pulmonary blastoma: An unusual presentation with chest wall, rib, and pleural involvement
by: Dixit, Ramakant, et al.
Published: (2014)

Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy
by: Ichiyasu, Hidenori, et al.
Published: (2016)

Cytologic features of pulmonary blastoma
by: Shalini, CN Sai, et al.
Published: (2009)

Carcinoma of Unknown Primary Site Treated with Carboplatin + Paclitaxel + Bevacizumab + Erlotinib and Its Maintenance Chemotherapy
by: Yasui, Hirotoshi, et al.
Published: (2014)

Primary pulmonary blastoma of monophasic variety- diagnosis and management
by: Mistry, Jitendra H, et al.
Published: (2013)

Pulmonary Blastoma: A Rare Primary Lung Malignancy
by: Alahwal, Mahmoud S., et al.
Published: (2012)

Pulmonary blastoma: a case report and review of the literature
by: Smyth, Robert J, et al.
Published: (2014)

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
by: YOKOI, TAKASHI, et al.
Published: (2014)

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
by: MARCHION, DOUGLAS C., et al.
Published: (2013)

Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: A case report
by: SHIMA, HIROSHI, et al.
Published: (2016)

Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
by: Wang, Ruo-Xi, et al.
Published: (2016)

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
by: Ceresoli, G L, et al.
Published: (2013)

Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma
by: Lv, Xing, et al.
Published: (2016)

Comparing Docetaxel Plus Cisplatin with Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer: a Single Institute Study
by: Khodadad, Kian, et al.
Published: (2014)

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
by: Dessai, S. B., et al.
Published: (2016)

A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non–small-cell lung cancer
by: Hasegawa, Takaaki, et al.
Published: (2016)

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers
by: Liu, Ke-Jun, et al.
Published: (2014)

A Malignant Cystic Hæmangio-Blastoma of the Cerebellum
by: Morrison, R. V., et al.
Published: (1937)

Pleuropulmonary Blastoma in Children: A Case Report
by: Hashemi, Azamsadat, et al.
Published: (2012)

Pleuropulmonary Blastoma: A Case Report and Review of the Literature
by: Khan, Amjad Ali, et al.
Published: (2014)

A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma
by: Zhao, Yuan-Yuan, et al.
Published: (2016)

A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer.
by: Siddiqui, N., et al.
Published: (1997)

Expression of Drug Targets in Patients Treated with Sorafenib, Carboplatin and Paclitaxel
by: Jilaveanu, Lucia B., et al.
Published: (2013)

nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma
by: Makimoto, Go, et al.
Published: (2014)

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
by: Alexandra Sokolova, et al.
Published: (2017-04-01)

Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy
by: Roskies, M., et al.
Published: (2016)

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer
by: Dermitzakis, Emmanouil V., et al.
Published: (2016)

Repetitive responses to nanoparticle albumin‐bound paclitaxel and carboplatin in malignant pleural mesothelioma
by: Kanai, Osamu, et al.
Published: (2016)

Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models
by: Oliva, P, et al.
Published: (2012)

Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review
by: He, Wan, et al.
Published: (2016)

Successful Treatment with Pemetrexed, Carboplatin, and Bevacizumab for Platinum-Resistant Adenocarcinoma of the Lung
by: Wada, Sae, et al.
Published: (2012)

Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
by: Kitchen, D, et al.
Published: (2013)

Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
by: Giovannoni, Sara, et al.
Published: (2014)

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III–IV Ovarian Serous Carcinoma
by: Kawaguchi, R., et al.
Published: (2012)

Reduction in Circulating Tumor Cell Count following Therapy with nab®-Paclitaxel plus Carboplatin in a Patient with Leptomeningeal Carcinomatosis from Breast Cancer
by: Stebel, Andrea
Published: (2012)

Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer
by: Shakir, Abdur R.
Published: (2014)

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors
by: Molife, L Rhoda, et al.
Published: (2014)